MedPath

Evaluation of the effects of PanRetinal Photocoagulation in Diabetic Retinopathy

Not Applicable
Conditions
Health Condition 1: H352- Other non-diabetic proliferative retinopathy
Registration Number
CTRI/2021/01/030217
Lead Sponsor
Maulana Azad Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects in the age range of 40-70 years, undergoing full panretinal photocoagulation , for very severe non-proliferative diabetic retinopathy and early proliferative diabetic retinopathy

Subjects having best corrected visual acuity of at least 6/60

Exclusion Criteria

Subjects having other significant ocular or systemic diseases like glaucoma, media opacity, optic atrophy, retinal disease, central nervous system disease or tumours

Subjects with history of previous treatment for diabetic retinopathy including anti-VEGF and laser

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Optical Coherence Tomography Angiography parameters ( Foveal Avascular Zone)Timepoint: 3 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1. Changes in Optical Coherence Tomography Angiography parameters ( Central Macular Thickness) <br/ ><br>2. Changes in Optical Coherence Tomography parameters (Retinal Nerve Fibre Layer)Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath